Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery.


Journal

Anesthesiology
ISSN: 1528-1175
Titre abrégé: Anesthesiology
Pays: United States
ID NLM: 1300217

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 27 2 2020
medline: 15 7 2020
entrez: 27 2 2020
Statut: ppublish

Résumé

In 2014, the U.S. Drug Enforcement Agency reclassified hydrocodone from Schedule III to Schedule II of the Controlled Substances Act, resulting in new restrictions on refills. The authors hypothesized that hydrocodone rescheduling led to decreases in total opioid dispensing within 30 days of surgery and reduced new long-term opioid dispensing among surgical patients. The authors studied privately insured, opioid-naïve adults undergoing 10 general or orthopedic surgeries between 2011 and 2015. The authors conducted a differences-in-differences analysis that compared overall opioid dispensing before versus after the rescheduling rule for patients treated by surgeons who frequently prescribed hydrocodone before rescheduling (i.e., patients who were functionally exposed to rescheduling's impact) while adjusting for secular trends via a comparison group of patients treated by surgeons who rarely prescribed hydrocodone (i.e., unexposed patients). The primary outcome was any filled opioid prescription between 90 and 180 days after surgery; secondary outcomes included the 30-day refill rate and the amount of opioids dispensed initially and at 30 days postoperatively. The sample included 65,136 patients. The percentage of patients filling a prescription beyond 90 days was similar after versus before rescheduling (absolute risk difference, -1.1%; 95% CI, -2.3% to 0.1%; P = 0.084). The authors estimated the rescheduling rule to be associated with a 45.4-mg oral morphine equivalent increase (difference-in-differences estimate; 95% CI, 34.2-56.7 mg; P < 0.001) in initial opioid dispensing, a 4.1% absolute decrease (95% CI, -5.5% to -2.7%; P < 0.001) in refills within 30 days, and a 37.7-mg oral morphine equivalent increase (95% CI, 20.6-54.8 mg; P = 0.008) in opioids dispensed within 30 days. Among patients treated by surgeons who frequently prescribed hydrocodone before the Drug Enforcement Agency 2014 hydrocodone rescheduling rule, rescheduling did not impact long-term opioid receipt, although it was associated with an increase in opioid dispensing within 30 days of surgery.

Sections du résumé

BACKGROUND
In 2014, the U.S. Drug Enforcement Agency reclassified hydrocodone from Schedule III to Schedule II of the Controlled Substances Act, resulting in new restrictions on refills. The authors hypothesized that hydrocodone rescheduling led to decreases in total opioid dispensing within 30 days of surgery and reduced new long-term opioid dispensing among surgical patients.
METHODS
The authors studied privately insured, opioid-naïve adults undergoing 10 general or orthopedic surgeries between 2011 and 2015. The authors conducted a differences-in-differences analysis that compared overall opioid dispensing before versus after the rescheduling rule for patients treated by surgeons who frequently prescribed hydrocodone before rescheduling (i.e., patients who were functionally exposed to rescheduling's impact) while adjusting for secular trends via a comparison group of patients treated by surgeons who rarely prescribed hydrocodone (i.e., unexposed patients). The primary outcome was any filled opioid prescription between 90 and 180 days after surgery; secondary outcomes included the 30-day refill rate and the amount of opioids dispensed initially and at 30 days postoperatively.
RESULTS
The sample included 65,136 patients. The percentage of patients filling a prescription beyond 90 days was similar after versus before rescheduling (absolute risk difference, -1.1%; 95% CI, -2.3% to 0.1%; P = 0.084). The authors estimated the rescheduling rule to be associated with a 45.4-mg oral morphine equivalent increase (difference-in-differences estimate; 95% CI, 34.2-56.7 mg; P < 0.001) in initial opioid dispensing, a 4.1% absolute decrease (95% CI, -5.5% to -2.7%; P < 0.001) in refills within 30 days, and a 37.7-mg oral morphine equivalent increase (95% CI, 20.6-54.8 mg; P = 0.008) in opioids dispensed within 30 days.
CONCLUSIONS
Among patients treated by surgeons who frequently prescribed hydrocodone before the Drug Enforcement Agency 2014 hydrocodone rescheduling rule, rescheduling did not impact long-term opioid receipt, although it was associated with an increase in opioid dispensing within 30 days of surgery.

Identifiants

pubmed: 32101973
doi: 10.1097/ALN.0000000000003188
pmc: PMC7160003
mid: NIHMS1068783
doi:

Substances chimiques

Analgesics, Opioid 0
Controlled Substances 0
Hydrocodone 6YKS4Y3WQ7

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1151-1164

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA042299
Pays : United States

Références

JAMA Surg. 2018 Dec 1;153(12):1111-1119
pubmed: 30140896
JAMA. 2014 Dec 10;312(22):2401-2
pubmed: 25490331
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
J Gen Intern Med. 2017 Jan;32(1):21-27
pubmed: 27484682
Ann Surg. 2019 May;269(5):873-878
pubmed: 29557880
Pharmacoepidemiol Drug Saf. 2018 May;27(5):513-519
pubmed: 29271049
J Am Geriatr Soc. 2018 May;66(5):945-953
pubmed: 29656382
Med Care. 2007 Oct;45(10 Supl 2):S116-22
pubmed: 17909369
JAMA Surg. 2017 Jun 21;152(6):e170504
pubmed: 28403427
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269
pubmed: 28301454
J Clin Oncol. 2017 Dec 20;35(36):4042-4049
pubmed: 29048972
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Mayo Clin Proc. 2017 Dec;92(12):1822-1830
pubmed: 29108841
Surgery. 2018 Oct;164(4):879-886
pubmed: 30093274
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Fed Regist. 2014 Aug 22;79(163):49661-82
pubmed: 25167591
Annu Rev Public Health. 2018 Apr 1;39:453-469
pubmed: 29328877
Stat Methods Med Res. 2019 Dec;28(12):3697-3711
pubmed: 30474484
N Engl J Med. 2018 Aug 9;379(6):504-506
pubmed: 30089064
N Engl J Med. 2017 Feb 16;376(7):663-673
pubmed: 28199807
Int J Biostat. 2007;3(1):Article 14
pubmed: 19655038
JAMA Intern Med. 2016 Mar;176(3):399-402
pubmed: 26809459
J Hand Surg Am. 2016 Oct;41(10):947-957.e3
pubmed: 27692801
Epidemiology. 2006 May;17(3):268-75
pubmed: 16617275
Lancet. 2019 Apr 13;393(10180):1547-1557
pubmed: 30983590

Auteurs

Mark D Neuman (MD)

From the Department of Anesthesiology and Critical Care (M.D.N., L.G.) Center for Perioperative Outcomes Research and Transformation (M.D.N., L.G.) Center for Pharmacoepidemiology Research and Training (M.D.N., S.H., D.S.S.) Department of Biostatistics, Epidemiology, and Informatics (S.H.) Center for Clinical Epidemiology and Biostatistics (S.H., D.S.S.,C.N., C.M.B.), Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania (M.D.N., S.H., D.S.S.) Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania (D.S.S.) Department of Anesthesia, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada (D.N.W.) Department of Anesthesia, Perioperative, and Pain Medicine and Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (B.T.B.) Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (H.W.) Department of Anesthesia and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada (H.W.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH